Urticaria
📧 Sign up to get email alerts when something new happens for Urticaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-05-21FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for a generic version of levocetirizine dihydrochloride from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2018-05-14FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC, approving the supplemental action relat…
-
CLINICAL_TRIALS withdrawal · 2018-05-01Clinical Trial Update: Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation [Phase 4]
A Phase 4 trial evaluating high-dose vitamin D to sustain urticaria remission after discontinuation of omalizumab; the study has been withdr…
-
CLINICAL_TRIALS other · 2018-04-19Clinical Trial Update: Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients [NA]
The clinical trial assessing a Brief Behavioral Activation Intervention for patients with depression and comorbid asthma and urticaria has b…
-
FDA approval · 2018-04-18FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Claritin Liqui-Gels (loratadine) as a new dosage form in the Claritin product line, manufactu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-04-16FDA Approved: LORATADINE — Original Application (Wal-Mart Stores, Inc)
FDA approves Wal-Mart Stores, Inc.'s original ANDA for loratadine (generic antihistamine) to treat allergy symptoms.
-
FDA approval · 2018-02-15FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin chewable grape and bubblegum formulations (loratadine) from Bayer HealthCare LLC. This …
-
FDA approval · 2018-01-12FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) filed by Bayer HealthCare LLC. This action confirms a supplemental approva…
-
CLINICAL_TRIALS trial_result · 2018-01-11Clinical Trial Update: To Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory Urticaria [Phase 1, Phase 2]
Clinical trial comparing cyclosporine and azathioprine for chronic refractory urticaria has completed phases 1 and 2.
-
FDA approval · 2017-12-22FDA Approved: CURIST ALLERGY RELIEF — Original Application (Little Pharma, Inc.)
FDA approves CURIST ALLERGY RELIEF through an original ANDA for cetirizine hydrochloride, authorizing the generic for allergy symptom relief…
-
FDA approval · 2017-12-08FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) by Kenvue Brands LLC. The approval confirms the ceti…
-
FDA approval · 2017-11-09FDA Approved: CHILDRENS FEXOFENADINE HYDROCHLORIDE ALLERGY — Original Application (Wal-Mart Stores Inc)
FDA approved a generic version of fexofenadine hydrochloride for pediatric allergy uses under an Original Application with Wal-Mart Stores I…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or Lupus
A clinical trial update examining patient-centered care and health-related quality of life in people with psoriasis, urticaria, or systemic …
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria [Phase 2]
Phase 2 trial evaluating the efficacy and safety of omalizumab (Xolair) for chronic urticaria.
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Methotrexate in the Treatment of Chronic Idiopathic Urticaria [Phase 3]
Phase 3 clinical trial update for methotrexate in chronic idiopathic urticaria has completed.
-
FDA approval · 2017-08-31FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)
FDA approved a supplemental application for levocetirizine dihydrochloride from Marlex Pharmaceuticals, updating an existing approved produc…
-
FDA approval · 2017-07-21FDA Approved: ALLERGY RELIEF — Original Application (WALMART INC. (see also Equate))
FDA approved Walmart's ALLERGY RELIEF containing cetirizine hydrochloride as an original generic application (ANDA 205291) for allergy relie…
-
FDA approval · 2017-07-10FDA Approved: ALLERGY RELIEF CHILDRENS — Supplemental Application (CVS Pharmacy)
FDA approved a supplemental application for CVS Pharmacy's ALLERGY RELIEF CHILDRENS cetirizine hydrochloride product.
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Quality of Life in Patients With Chronic Urticaria
This clinical trial update focuses on quality of life in patients with chronic urticaria; the current status is not disclosed.
-
FDA approval · 2017-05-22FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum (loratadine) from Bayer HealthCare LLC. The approval expan…
-
FDA approval · 2017-05-19FDA Approved: CYPROHEPTADINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a generic cyproheptadine hydrochloride product from Zydus Pharmaceuticals USA Inc (ANDA 208938). Indications include relief of …
-
FDA approval · 2017-05-16FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer Healthcare LLC. Claritin RediTabs is an antihistamine …
-
FDA label_change · 2017-04-26FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) by Bayer HealthCare LLC to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome [Phase 4]
Phase 4 study assessing whether genetic screening for HLA-B*1301 can predict susceptibility to dapsone hypersensitivity syndrome.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Animal Allergy in Korean Veterinary Researcher
This clinical trial update describes a study on animal allergy conducted by a Korean veterinary researcher. Conditions include allergic rhin…